Dana-Farber Cancer Insitute — Boston, Massachusetts

Dana-Farber Cancer Insitute is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Insitute has participated in 11 clinical trials with 3 currently active.

Therapeutic areas: Neoplasms, Solid Tumor, Adult, Metastatic Breast Cancer.

Sponsors: Pfizer, TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics), Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Insitute?

Dana-Farber Cancer Insitute has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Insitute conducted?

Dana-Farber Cancer Insitute has 11 clinical trials on record, with 3 currently active. Their work covers Neoplasms, Solid Tumor, Adult, Metastatic Breast Cancer.

Is Dana-Farber Cancer Insitute accredited by Crixeo Health?

Yes — Dana-Farber Cancer Insitute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Dana-Farber Cancer Insitute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.